Skip to main content
. 2019 Jan 9;41(3):1707–1717. doi: 10.3892/or.2019.6961

Figure 2.

Figure 2.

Figure 2.

Figure 2.

AQP4 promotes oxygen glucose deprivation (OGD)/RX-induced astrocyte cell injury. (A and B) Cell viability assay of OGD/RX-treated primary cultured astrocytes transfected with miR-29 mimic, or negative controls (NC), following propidium iodide (PI)/calcein staining. ***P<0.001 vs. NC; ###P<0.001 vs. OGD/RX+NC (n=3 for each experiment). (C) Expression of LDH determined by ELISA. ***P<0.001 vs. NC; ###P<0.001 vs. OGD/RX+NC (n=3). (D and E) Flow cytometric analysis of apoptotic cells among OGD/RX-induced astrocytes transfected with miR-29a mimic or NC. ***P<0.001 vs. NC; ###P<0.001 vs. OGD/RX+NC (n=3). (F and G) Cell heath assay of OGD/RX-treated primary cultured astrocytes transfected with miR-29 inhibitor or NC followed by PI/calcein staining. **P<0.01, ***P<0.001 vs. NC; ##P<0.01, ###P<0.001 vs. OGD/RX+inhibitor NC (n=3). (H) Expression of LDH detected by ELISA. ***P<0.001 vs. NC; ###P<0.001 vs. OGD/RX+inhibitor NC (n=3 for each experiment). (I and J) Rate of apoptosis determined by flow cytometry in OGD/RX-induced astrocytes transfected with miR-29a inhibitor or NC. ***P<0.001 vs. NC; #P<0.05 vs. OGD/RX+inhibitor NC (n=3 for each experiment). (K and L) Western blotting of the expression of Bax and Bcl-2 in OGD/RX-induced astrocytes transfected with miR-29a mimic, inhibitor, or NC. OGD/RX, oxygen glucose deprivation-reoxygenation; AQP4, aquaporin 4; PI, propidium iodide.